Equities

Holdco Nuvo Group DG Ltd

NUVO:NMQ

Holdco Nuvo Group DG Ltd

Actions
FinancialsOpen End and Miscellaneous Investment Vehicles
  • Price (USD)0.848
  • Today's Change0.145 / 20.63%
  • Shares traded114.79k
  • 1 Year change-91.95%
  • Beta--
Data delayed at least 15 minutes, as of Jul 26 2024 20:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Holdco Nuvo Group D.G Ltd is an Israel-based company engaged primarily in medical technologies related to pregnancy care. The Company focuses its efforts on the provision of remote pregnancy monitoring. The Company achieves its goal of remote pregnancy care through its digital platform INVU. The Platform enables constant monitoring of a pregnant woman and the state of the pregnancy. The Company provides the patient with a device for monitoring as well as a mobile application for communication with medical specialists. The Platform allows multiple nonstress tests (NST) to be performed by the patient regardless of time and place, as well as collection of the medical data by the medical specialist responsible for the pregnancy care. The Company develops its solutions with the goal of the safety of the pregnancy, as well as availability of healthcare.

  • Revenue in USD (TTM)0.00
  • Net income in USD-3.49m
  • Incorporated2023
  • Employees--
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
NUVO:NMQ since
announced
Transaction
value
Nuvo Group LtdAnnounced17 Aug 202317 Aug 2023Announced-91.98%--
Data delayed at least 15 minutes, as of Jul 26 2024 20:59 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Ekso Bionics Holdings Inc17.91m-14.24m23.63m70.00--1.67--1.32-0.9685-0.96851.200.77650.54231.653.38255,900.00-43.11-43.63-57.86-57.6750.4151.93-79.48-104.242.11-34.630.2937--41.5710.03-0.7825--3.69--
Autonomix Medical Inc0.00-15.43m24.31m5.00--3.19-----0.7614-0.76140.000.4048------0.00--------------------0.1161-------674.99------
Femasys Inc1.05m-14.90m25.33m32.00--1.61--24.15-0.8567-0.85670.05880.70630.05490.49398.5832,785.00-77.93---86.46--65.35---1,420.27--8.02--0.3057---11.13---25.04------
Meihua International Medical Tech Co Ltd97.10m11.63m25.96m617.002.100.16692.150.26740.48560.48564.066.110.578846.661.31157,372.606.9112.268.1315.0534.1938.1411.9415.475.21--0.04750.00-6.055.1086.22-5.56-9.16--
Trinity Biotech plc (ADR)56.71m-33.88m27.07m380.00------0.4774-4.42-2.817.41-14.960.6251.693.67149,229.00-37.34-20.30-47.55-29.5434.2139.92-59.75-29.861.03-1.961.36---9.10-10.1515.41---31.08--
Holdco Nuvo Group DG Ltd0.00-3.49m28.21m----0.7798-----0.3581-0.35810.001.090.00-------2.34---2.40--------------0.00-------255.01------
Accelerate Diagnostics Inc12.17m-59.05m28.67m134.00------2.36-4.54-4.540.82-1.180.29782.055.2490,805.97-144.52-75.24---94.4628.3235.08-485.31-638.551.29--2.93---5.4316.291.40--0.7307--
Beyond Air Inc1.16m-60.24m29.15m107.00--1.16--25.15-1.83-1.830.0350.54570.01841.511.9310,831.78-102.29-78.25-145.94-99.91-112.77---5,547.37-6,152.993.61-55.710.3634-----31.57-7.93--152.05--
Cutera Inc196.64m-157.56m30.55m430.00------0.1554-7.89-7.899.86-9.600.48642.294.43457,293.00-38.97-22.00-50.24-30.7216.4247.63-80.13-27.242.22-43.941.84---15.865.47-97.76--85.87--
Positron Corp1.24m-1.27m30.66m22.00------24.79-0.0897-0.08970.0876-0.11090.59762.296.56---61.35-224.13----32.989.85-102.67-201.870.0638-------10.060.275163.63--4.36--
Spectral AI Inc19.30m-20.45m31.29m78.00------1.62-1.50-1.501.36-0.1161.30--9.42247,487.20-137.87---601.38--44.78---105.94--0.837--1.54---28.82---616.14------
bioAffinity Technologies Inc4.94m-8.37m31.59m75.00--5.78--6.40-0.9197-0.91970.54160.46870.5334318.228.7065,839.60-90.38---104.93--32.88---169.42--2.21--0.1782--52,660.42--2.66------
Know Labs Inc0.00-20.70m31.81m14.00---------0.3451-0.34510.00-0.02130.00----0.00-254.68-209.16-937.53-1,087.76-------1,302.62---23.611.47---100.00---1.85---3.64--
IRIDEX Corp49.92m-10.94m33.32m111.00--5.14--0.6674-0.6759-0.67593.080.39921.332.667.42449,765.80-29.16-19.54-47.74-27.4640.7242.67-21.92-15.451.03--0.00---8.964.02-26.81---24.35--
Data as of Jul 26 2024. Currency figures normalised to Holdco Nuvo Group DG Ltd's reporting currency: US Dollar USD

Institutional shareholders

3.35%Per cent of shares held by top holders
HolderShares% Held
W.R. Berkley Corp. (Investment Portfolio)as of 31 Mar 2024485.71k1.46%
Centiva Capital LPas of 31 Mar 2024199.06k0.60%
Raymond James & Associates, Inc. (Invt Mgmt)as of 30 Jun 2024100.00k0.30%
Periscope Capital, Inc.as of 31 Mar 2024100.00k0.30%
AQR Arbitrage LLCas of 31 Mar 202482.00k0.25%
Clear Street LLCas of 31 Mar 202470.29k0.21%
Robinson Capital Management LLCas of 31 Mar 202432.01k0.10%
Tidal Investments LLCas of 31 Mar 202432.01k0.10%
Geode Capital Management LLCas of 31 Mar 202413.87k0.04%
Tower Research Capital LLCas of 31 Mar 2024188.000.00%
More ▼
Data from 31 Mar 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.